Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In the SURMOUNT trials, participants reported not only significant reductions in body weight, but improvements in physical function, quality of life, and overall wellbeing
Updates log 26 May 2026: First publication
Your healthcare provider will advise the best schedule for you
CSL Vifor and Travere Therapeutics proudly support these updated recommendations, spotlighting FILSPARI (sparsentan) as a groundbreaking, non-immunosuppressive therapy transforming patient care
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
